kidney failure

Search with Google Search with Bing
Information
Disease name
kidney failure
Disease ID
DOID:1074
Description
"A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood." [url:http\://en.wikipedia.org/wiki/Renal_failure, url:http\://www.nlm.nih.gov/medlineplus/kidneyfailure.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05112315 Active, not recruiting N/A Clinical Impact of the iBox as an Early Intervention tooL February 18, 2022 November 2024
NCT02194582 Active, not recruiting Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure June 1996 January 2035
NCT04605679 Active, not recruiting N/A Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients May 6, 2020 December 2024
NCT03099434 Active, not recruiting N/A Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media April 1, 2017 July 7, 2024
NCT04796558 Active, not recruiting Validation of Arterio Venous Access Stage (AVAS) Classification April 1, 2021 December 31, 2024
NCT00167947 Completed Phase 3 Study Evaluating Sirolimus in Kidney Transplant Recipients. January 2005 July 2007
NCT00183248 Completed Phase 1/Phase 2 Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients September 2004 November 2009
NCT00195429 Completed Phase 4 A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients August 2005 October 2007
NCT00195468 Completed Phase 4 Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus March 2004 November 2006
NCT00195481 Completed Phase 4 Study Evaluating Sirolimus in Kidney Transplant Recipients in India April 2004 December 2005
NCT00202345 Completed Phase 3 Iron Sucrose in Stage 3/4 Kidney Disease August 2004 February 2007
NCT00211653 Completed Phase 1/Phase 2 Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery April 2003 November 2006
NCT00211978 Completed Phase 3 EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) May 2005 October 2006
NCT00213590 Completed Phase 3 Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients April 2000 November 2006
NCT00001859 Completed Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant June 4, 1999 May 30, 2014
NCT00001959 Completed Phase 2 Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) December 1999 October 2008
NCT00006178 Completed Phase 2 Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection August 2000 December 2007
NCT00067119 Completed Phase 3 Aggrenox Prevention of Access Stenosis January 1, 2003 January 31, 2008
NCT00150943 Completed Phase 3 Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis June 2000
NCT00266123 Completed Phase 4 Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients March 2004 July 2007
NCT00273871 Completed Phase 3 Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients January 2002 September 2006
NCT00282217 Completed Phase 4 Study Evaluating Sirolimus in the Treatment of Kidney Transplant August 2006
NCT00294866 Completed Phase 4 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients March 2006 January 2008
NCT00317252 Completed Phase 2 Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization July 2006 March 2012
NCT00323128 Completed Phase 1 Validation of Serum Creatinine Dosage and Renal Clearance May 2006 December 2010
NCT00356954 Completed Phase 4 NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization February 2005 April 2006
NCT00364260 Completed Phase 3 A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. December 1997 August 2003
NCT00369382 Completed Phase 4 Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients September 2006 May 2010
NCT00396435 Completed Phase 4 Correction of Anaemia and Progression of Renal Failure on Transplanted Patients April 2004 May 2010
NCT00526747 Completed Erythropoietin Resistance in Anemia of Chronic Kidney Disease August 2007 June 2008
NCT00551655 Completed Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients May 2007 September 2007
NCT00645658 Completed N/A Testosterone Replacement Therapy in Advanced Chronic Kidney Disease August 2007 August 2010
NCT00700531 Completed N/A European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy June 2008 October 2015
NCT00744939 Completed Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist November 2008 November 2013
NCT00748072 Completed Phase 4 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy August 2008 December 2009
NCT00765661 Completed Phase 2 Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients September 2008 February 2010
NCT00780845 Completed AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG) January 2003 January 2008
NCT00815867 Completed Phase 3 Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant October 2007 September 2009
NCT00906204 Completed Phase 2 Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation March 2010 July 2014
NCT00919438 Completed Non Invasive External Monitoring in Dialysis Patients January 2009 September 2009
NCT01021839 Completed N/A Comparison of Bovine Carotid Artery and Expanded Polytetrafluoroethylene (ePTFE) for Permanent Hemodialysis Access April 2006 June 2009
NCT01158742 Completed Live Kidney Donor Study -Renal Function Study September 2009 June 2012
NCT01160978 Completed Phase 2/Phase 3 Donor Simvastatin Treatment in Organ Transplantation June 1, 2010 August 1, 2016
NCT01191255 Completed Phase 3 A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis October 2010 February 2013
NCT01231438 Completed Phase 2 Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. October 2010 March 2011
NCT01289548 Completed N/A Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation May 2010 January 2012
NCT01423955 Completed Phase 2 Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery October 2011 April 2013
NCT01429038 Completed Phase 1/Phase 2 Mesenchymal Stem Cells After Renal or Liver Transplantation February 1, 2012 March 11, 2019
NCT01447368 Completed Phase 4 Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients May 10, 2010 May 22, 2017
NCT01471041 Completed Phase 2/Phase 3 Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae December 2011 June 2013
NCT01536548 Completed N/A Indicating Direction and Angle for Cannulating of AV-fistula in Hemodialysis Patients March 2012 July 2012
NCT01554982 Completed Phase 3 A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis August 2012 August 2014
NCT01564966 Completed Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation April 2008 December 2011
NCT01756508 Completed Phase 2 Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury September 1, 2012 December 1, 2017
NCT01860183 Completed Phase 4 Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis May 2013 June 1, 2016
NCT01879124 Completed Resistive Index Measurements After Kidney Transplantation March 2004 June 2012
NCT01894906 Completed Phase 1/Phase 2 Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients July 2013 September 2013
NCT01912001 Completed N/A Virtual Ward for Home Dialysis September 2013 March 2016
NCT01974999 Completed A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study October 2013 July 2014
NCT02134314 Completed Phase 1/Phase 2 C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI September 2014 March 13, 2017
NCT02159209 Completed The Drug Induced Renal Injury Consortium February 2013 December 2015
NCT02491580 Completed Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer October 2014 June 2015
NCT02512731 Completed N/A Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation June 2012 December 2016
NCT02546037 Completed Clotting With Different Dialyzer Membranes September 30, 2016 July 30, 2017
NCT02607111 Completed Phase 4 A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients August 2016 July 30, 2018
NCT02705417 Completed Maximizing Native Arteriovenous Fistulae Rates. January 2012 January 2015
NCT02717533 Completed Blood Volume Analysis and Renal Outcomes in Hemodialysis January 2014 January 2015
NCT02753868 Completed N/A Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients February 2016 February 2017
NCT02785445 Completed N/A Healthy.io Method Comparison & User Performance Study October 2015 September 2017
NCT02830464 Completed New Biomarkers in Heart- and Renal Failure August 2016 June 2018
NCT02926846 Completed Phase 4 IV Antibiotics With Lavage for Severe PD Peritonitis March 2014 January 2018
NCT03194750 Completed N/A Ultrasound Assessment of Volume in Patients on Continuous Dialysis June 1, 2016 September 7, 2023
NCT03242343 Completed N/A VasQ External Support for Arteriovenous Fistula November 29, 2017 April 3, 2022
NCT03289520 Completed Phase 3 Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis January 7, 2003 June 18, 2007
NCT03329521 Completed N/A Enhance Access to Kidney Transplantation and Living Kidney Donation November 1, 2017 December 31, 2021
NCT03332186 Completed Phase 1 A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function March 15, 2018 October 22, 2018
NCT03708094 Completed Prognosis Study of Renal Transplantation in Children November 1, 2018 December 30, 2021
NCT03714789 Completed Clearance and Pharmacokinetics of Antibiotics in Renal Replacement Therapy November 1, 2017 October 1, 2020
NCT03723668 Completed Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France October 9, 2017 March 29, 2020
NCT03794817 Completed Immune Monitoring in Sensitized Patients at Risk of Rejection August 20, 2015 September 8, 2017
NCT03836508 Completed N/A Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis September 1, 2018 July 1, 2019
NCT03925454 Completed FREquent DIalysis & Markers of Cardiac Strain and Injury, Physical Fitness, Habitual Physical Activity & Quality of Life March 19, 2019 January 13, 2022
NCT03988270 Completed N/A Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy June 17, 2019 November 9, 2021
NCT04016311 Completed N/A A Brief Mindful Drinking/Eating Intervention for Hemodialysis Patients With Fluid Restrictions June 25, 2019 May 7, 2020
NCT04261205 Completed Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre August 4, 2018 November 13, 2020
NCT04510090 Completed Phase 1 Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus September 7, 2020 July 8, 2021
NCT04515797 Completed Phase 4 QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir May 1, 2021 August 31, 2023
NCT04641650 Completed Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsis July 21, 2021 November 9, 2022
NCT05272800 Completed N/A BIS-guided Fluid Management in HD Patients September 1, 2019 September 1, 2021
NCT05697458 Completed Vascular Calcifications in Kidney Transplant Recipient December 1, 2022 January 31, 2024
NCT05842772 Completed N/A Feasibility Testing a shareD dEciSIon Making Intervention for People With Kidney failuRE, Their Relatives, and the Health Professionals in Kidney Services: a Pilot Randomized Controlled Trial Study Protocol March 20, 2023 October 6, 2023
NCT05943977 Completed Phase 3 A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants March 2, 2023 November 30, 2023
NCT06040684 Completed Development of Antibodies Against Transplant Kidney After Infection August 1, 2018 December 31, 2021
NCT00246129 Completed Phase 4 CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation October 2005 June 2011
NCT00247325 Completed Phase 4 RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography January 2004 December 2004
NCT00254709 Completed Phase 4 Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients October 2002 September 2005
NCT00259441 Completed Phase 4 PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography February 2005 March 2006
NCT00261820 Completed Phase 4 Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients January 2005
NCT05324878 Enrolling by invitation Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis September 1, 2021 July 1, 2024
NCT06141499 Enrolling by invitation N/A Using Shared Decision Making to Improve Kidney Transplantation Rates January 12, 2024 January 20, 2025
NCT05374291 Enrolling by invitation Phase 3 The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD November 8, 2022 January 2027
NCT03171545 Enrolling by invitation N/A Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe) January 11, 2023 September 30, 2026
NCT06243731 Not yet recruiting A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation May 30, 2025 January 31, 2027
NCT05021731 Not yet recruiting Phase 4 Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease April 20, 2024 April 30, 2025
NCT06351813 Not yet recruiting Predicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers July 1, 2024 December 31, 2027
NCT06343727 Not yet recruiting N/A A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) May 1, 2024 July 1, 2025
NCT06082063 Not yet recruiting N/A Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes February 1, 2024 January 1, 2030
NCT05031052 Recruiting N/A Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation May 10, 2022 December 31, 2025
NCT04671771 Recruiting N/A A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access December 3, 2020 August 1, 2029
NCT04714853 Recruiting Different Dialysis Modalities and Diet on Gastrointestinal Biome and Azotaemic Toxins October 2015 December 2024
NCT00026702 Recruiting Search for New Methods to Detect Acute Renal Failure June 7, 2000
NCT04932148 Recruiting N/A INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD) July 6, 2022 August 2026
NCT03065972 Recruiting N/A Hemodialysis in the Elderly (70yrs & Older) January 28, 2016 February 2025
NCT05179668 Recruiting Phase 2 SGLT2 Inhibition in Hemodialysis October 1, 2022 September 30, 2025
NCT05321706 Recruiting Phase 3 DAPAgliflozin for Renal Protection in Heart Transplant Recipients June 8, 2022 June 30, 2027
NCT03615235 Recruiting APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) March 21, 2019 May 2027
NCT03627013 Recruiting Phase 3 Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas) May 23, 2019 September 30, 2025
NCT05614115 Recruiting Phase 1 Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD March 21, 2023 March 31, 2025
NCT06298227 Recruiting N/A Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy March 11, 2024 July 30, 2024
NCT05777174 Recruiting Phase 3 Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring March 20, 2023 April 2024
NCT01331668 Recruiting BIOBANK Renal Transplantation University Hospitals Leuven March 2004 December 2099
NCT06337942 Recruiting N/A Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study July 1, 2024 April 2027
NCT05900401 Recruiting Phase 1/Phase 2 Delayed Tolerance Through Mixed Chimerism October 1, 2023 December 2030
NCT06053710 Recruiting N/A Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor November 13, 2023 December 31, 2024
NCT04277377 Recruiting Nanoparticle for DSA Removal October 5, 2021 February 28, 2026
NCT04447911 Recruiting Phase 4 Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia February 4, 2021 February 2025
NCT06056102 Recruiting Phase 1 CAR-T Cell Therapy for Desensitization in Kidney Transplantation May 9, 2024 December 15, 2042
NCT02343016 Terminated NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion February 2015 June 2015
NCT04626427 Terminated N/A The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation December 22, 2020 June 15, 2022
NCT03350269 Terminated N/A Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates November 15, 2017 October 20, 2020
NCT00881439 Terminated Phase 2 Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment April 2009 December 2012
NCT00260728 Terminated Phase 2/Phase 3 The Boston Scientific ACCESS Trial December 2005 December 2008
NCT00986947 Terminated Phase 2 Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates September 2009 July 2011
NCT01921829 Terminated Phase 4 Protocolized Diuretic Strategy in Cardiorenal Failure November 2013 November 2015
NCT05747053 Terminated Personalization of Immunosuppressive Treatment for Organ Transplant Recipients October 1, 2020 December 8, 2022
NCT01286506 Terminated Observational Study of Blood Pressure Measurements and Continuous Dialysis February 2011 December 2015
NCT03840343 Terminated Phase 1 Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease October 23, 2019 August 4, 2020
NCT00144118 Terminated Phase 4 The Effect of Isoflurane or Sevoflurane on Kidney Function January 2002 August 2005
NCT04063865 Terminated Phase 3 Everolimus Monotherapy as Immunosuppression After Liver Transplant May 9, 2019 July 2, 2020
NCT00311311 Terminated Phase 3 Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients April 2006 January 2012
NCT00306306 Terminated Phase 2/Phase 3 COOL RCN: Cooling to Prevent Radiocontrast Nephropathy March 2006 August 2007
NCT00213642 Terminated Tc-99m Renography and Cisplatin-induced Nephrotoxicity July 2001 August 2004
NCT00364494 Terminated N/A Hemodilution and Outcome in Cardiac Surgery November 2006 April 2007
NCT01725113 Terminated Phase 4 Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol November 2012 October 2015
NCT00150319 Terminated Phase 1/Phase 2 An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend June 2005 October 2005
NCT00450333 Terminated Phase 3 Dynepo Infrequent Dosing Study October 30, 2006 July 31, 2008
NCT00497926 Terminated Phase 2 Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion March 2008 April 2023
NCT04258423 Terminated Phase 3 Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function December 19, 2019 June 27, 2020
NCT01982903 Unknown status Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants July 2015 June 2019
NCT00599391 Unknown status Phase 1 Far Infrared Treatment for Kidney Diseases February 2008 February 2009
NCT01446484 Unknown status Phase 1/Phase 2 Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection October 2011 November 2014
NCT03845530 Unknown status N/A The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin March 2019 March 2020
NCT00173485 Unknown status The Study of Infection and Cell Inflammation in Peritoneal Dialysate June 2005 June 2009
NCT00257439 Unknown status Vitamin Metabolism in Kidney Disease December 2005
NCT02545920 Unknown status To Assess Ear Blood Flow During Dialysis September 2015 August 30, 2021
NCT03334123 Unknown status N/A Effects of Exercise and Exercise Counselling in Hemodialysis Patients. November 8, 2017 June 2019
NCT02450474 Unknown status N/A Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis February 2014 January 2016
NCT00806039 Unknown status N/A Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure December 2008 July 2009
NCT00310739 Unknown status Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury
NCT03791476 Unknown status Phase 1 RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function June 21, 2019 January 2022
NCT04988789 Unknown status Evaluation of Paclitaxel Coated Balloon in the Treatment of Dialysis Access Dysfunction April 1, 2020 December 31, 2023
NCT02435732 Unknown status Phase 1 CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60% December 2020 May 2022
NCT00242398 Unknown status Phase 3 Hemodialysis Without Anticoagulation in Intensive Care Unit October 2005 April 2008
NCT03418181 Unknown status N/A Does Incremental Initiation of Haemodialysis Preserve Native Kidney Function? January 8, 2018 March 2, 2019
NCT02447822 Unknown status Phase 4 Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg) June 2015 May 2018
NCT00006331 Unknown status Prospective Controlled Study of Posttransplant Diabetes
NCT01595984 Unknown status Phase 3 Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) May 3, 2012 August 2018
NCT00807274 Withdrawn Renal Function in Adults With Congenital Heart Disease. September 2008 December 2010
NCT00633308 Withdrawn Phase 2 Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions March 2008 February 2011
NCT04320290 Withdrawn Phase 4 HCV + to HCV - Kidney Transplant May 21, 2020 June 16, 2020
NCT02368249 Withdrawn Phase 2 Does Terlipressin Improve Renal Outcome After Liver Surgery January 2020 February 2025
NCT03623568 Withdrawn Phase 4 Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant February 15, 2019 April 15, 2021
Disase is a (Disease Ontology)
DOID:557
Cross Reference ID (Disease Ontology)
ICD10CM:N19
Cross Reference ID (Disease Ontology)
ICD9CM:586
Cross Reference ID (Disease Ontology)
MESH:D051437
Cross Reference ID (Disease Ontology)
NCI:C4376
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:42399005
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0035078
Exact Synonym (Disease Ontology)
renal failure